株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

吸引針・生検針の世界市場 - 2024年までの予測:穿刺吸引・生検 (コア生検・真空補助下生検)

Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 881638
出版日 ページ情報 英文 135 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
吸引針・生検針の世界市場 - 2024年までの予測:穿刺吸引・生検 (コア生検・真空補助下生検) Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024
出版日: 2019年07月01日 ページ情報: 英文 135 Pages
概要

世界の吸引針・生検針市場は、2019年の8億9400万米ドルから、2024年までに12億7200万米ドルまで拡大すると予測され、この間は7.3%のCAGR (複合年間成長率) が見込まれています。癌発生率の増加および低侵襲性の診断法を好む患者の増加により、吸引針・生検張りの導入は、主要なヘルスケア市場全体で拡大しています。

当レポートでは、世界の吸引針・生検針市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

881638_4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW_FIGURE 11

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 吸引針・生検針市場の概要
  • 吸引針・生検針市場のシェア:製品別
  • 吸引針・生検針市場:エンドユーザー別
  • 吸引針・生検針市場:診断法別
  • 吸引針・生検針市場:部位別
  • 吸引針・生検針市場:地域別

第5章 市場概要

  • 市場ダイナミクス
  • 産業動向

第6章 吸引針・生検針市場:製品別

  • イントロダクション
  • 吸引針
  • 生検針

第7章 吸引針・生検針市場:診断法別

  • イントロダクション
  • 画像誘導診断
    • 超音波
    • 定位固定
    • MRI
  • 非画像誘導診断

第8章 吸引針・生検針市場:部位別

  • イントロダクション
  • 胸部
  • 大腸
  • 前立腺
  • 肝臓
  • 骨・骨髄
  • その他の部位

第9章 吸引針・生検針市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (ROW)

第10章 競合情勢

  • イントロダクション
  • 市場ランキング分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第11章 企業プロファイル

  • ARGON MEDICAL DEVICES, INC.
  • BECTON, DICKINSON AND COMPANY (BD)
  • BOSTON SCIENTIFIC CORPORATION
  • CARDINAL HEALTH, INC.
  • CONMED CORPORATION
  • COOK GROUP INCORPORATED
  • HAKKO CO.,LTD. MEDICAL DEVICE DIVISION
  • INRAD INC.
  • MEDTRONIC, PLC
  • MERIT MEDICAL SYSTEMS
  • オリンパス
  • RANFAC CORPORATION
  • REMINGTON MEDICAL INC.
  • SOMATEX MEDICAL TECHNOLOGIES
  • STRYKER CORPORATION

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 2: BIOPSY NEEDLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 3: BIOPSY NEEDLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: BIOPSY NEEDLES MARKET SPLIT , BY SITE, 2017-2024, (USD MILLION)
  • TABLE 5: BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2017-2024, (USD MILLION)
  • TABLE 6: BIOPSY NEEDLES MARKET SPLIT , BY END USER, 2017-2024, (USD MILLION)
  • TABLE 7: CNB NEEDLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CNB NEEDLES MARKET, BY SITE, 2017-2024, (USD MILLION)
  • TABLE 9: CNB NEEDLES MARKET, BY PROCEDURE, 2017-2024, (USD MILLION)
  • TABLE 10: CNB NEEDLES MARKET, BY END USER, 2017-2024, (USD MILLION)
  • TABLE 11: VAB NEEDLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: VAB NEEDLES MARKET, BY SITE, 2017-2024, (USD MILLION)
  • TABLE 13: VAB NEEDLES MARKET, BY PROCEDURE, 2017-2024, (USD MILLION)
  • TABLE 14: VAB NEEDLES MARKET, BY END USER, 2017-2024, (USD MILLION)
  • TABLE 15: ASPIRATION NEEDLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: ASPIRATION NEEDLES MARKET, BY SITE, 2017-2024, (USD MILLION)
  • TABLE 17: ASPIRATION NEEDLES MARKET, BY PROCEDURE, 2017-2024, (USD MILLION)
  • TABLE 18: ASPIRATION NEEDLES SPLIT, BY END USER, 2017-2024, (USD MILLION)
  • TABLE 19: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
  • TABLE 20: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: ASPIRATION AND BIOPSY NEEDLES MARKET FOR NONIMAGE-GUIDED PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017-2024 (USD MILLION)
  • TABLE 28: ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE AND BONE MARROW PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROCEDURES AT OTHER SITES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 43: ESTIMATED NEW CASES OF CANCER IN 2019
  • TABLE 44: US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 45: CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 46: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 48: EUROPE: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017-2024 (USD MILLION)
  • TABLE 50: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
  • TABLE 51: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 53: GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 54: UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 55: FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 56: ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 57: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 59: APAC: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017-2024 (USD MILLION)
  • TABLE 61: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
  • TABLE 62: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 64: JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 65: CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 66: INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 67: ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 68: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 69: ROW: BIOPSY NEEDLES MARKET, BY PRODUCT TYPE, 2017-2024 (USD MILLION)
  • TABLE 70: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2017-2024 (USD MILLION)
  • TABLE 71: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
  • TABLE 72: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURE, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 74: PRODUCT LAUNCHES AND APPROVALS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: PRODUCT-BASED MARKET SIZE ESTIMATION: ASPIRATION AND BIOPSY NEEDLES MARKET
  • FIGURE 5: END-USER BASED ESTIMATION: ASPIRATION AND BIOPSY NEEDLES MARKET
  • FIGURE 6: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019-2024 (USD MILLION)
  • FIGURE 7: ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2019-2024 (USD MILLION)
  • FIGURE 8: ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY PROCEDURE, 2019 VS 2024
  • FIGURE 9: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019-2024 (USD MILLION)
  • FIGURE 10: ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION
  • FIGURE 11: RISING PREVALENCE OF CANCER GLOBALLY IS A KEY DRIVER FOR THE MARKET
  • FIGURE 12: BIOPSY NEEDLES HELD THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 13: HOSPITALS COMMAND THE LARGEST SHARE OF THE MARKET
  • FIGURE 14: IMAGE-GUIDANCE PROCEDURES HOLD THE LARGEST SHARE OF THE MARKET
  • FIGURE 15: BREAST PROCEDURES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: INCIDENCE OF CANCER, BY COUNTRY/REGION, 2012-2020 (THOUSAND)
  • FIGURE 19: NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
  • FIGURE 20: EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
  • FIGURE 21: APAC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
  • FIGURE 22: ROW: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
  • FIGURE 23: ASPIRATION AND BIOPSY NEEDLES MARKET RANKING, BY KEY PLAYER, 2018
  • FIGURE 24: COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
  • FIGURE 25: BD: COMPANY SNAPSHOT
  • FIGURE 26: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT-2018
  • FIGURE 27: CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 28: CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 29: MEDTRONIC, PLC: COMPANY SNAPSHOT
  • FIGURE 30: MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • FIGURE 31: OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 32: STRYKER CORPORATION: COMPANY SNAPSHOT
目次
Product Code: MD 7195

"The aspiration and biopsy needles market is projected to grow at a CAGR of 7.3%."

The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures.

"The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period."

On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer.

"The Hospitals segment is expected to witness the highest growth during the forecast period."

On the basis of end user, the aspiration and biopsy needles market is segmented into hospitals, research laboratories & academic institutes, and diagnostic & imaging centers. The hospitals segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.

"On the basis of site, the breast segment is expected to hold the largest share of the market in 2019."

On the basis of site, the aspiration and biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow. The breast segment accounted for the largest share of the aspiration and biopsy needles market in 2019. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis

"Image-guided procedure segment is expected to witness the highest growth during the forecast period."

On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and nonimage-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.

"Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period."

Emerging economies such as India, China, and South Korea are offering high-growth opportunities for market players. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 45%, Tier 2 - 34%, and Tier 3 - 21%
  • By Designation: C-level - 28%, Director-level - 19%, and Others - 53%
  • By Region: North America - 35%, Europe - 32%, APAC - 25%, and RoW - 8%

The major players operating in the global aspiration and biopsy needles market are: CONMED Corporation(US), Medtronic Plc(Ireland), Olympus -Japan, Becton, Dickinson and Company(US), Boston Scientific Corporation(US), Cook Group Incorporated(US), Argon Medical Devices, Inc(US), INRAD Inc.(US), Somatex Medical Technologies(Germany), Stryker Corporation(US), Cardinal Health(US), Remington Medical(US), HAKKO CO.,LTD(Japan), and Merit Medical Systems(US).

Research Coverage:

This report studies the aspiration and biopsy needles market by product, site, procedure, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions-North America, Europe, Asia Pacific, and the Rest of the World.

Reasons to Buy the Report:

From an insights perspective, this research report focuses on various levels of analysis-market ranking the analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the aspiration and biopsy needles market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY USED FOR THE STUDY
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2. END USER-BASED MARKET ESTIMATION
    • 2.2.3. PRIMARY RESEARCH VALIDATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW
  • 4.2. ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY PRODUCT
  • 4.3. ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019 VS. 2024(USD MILLION)
  • 4.4. ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019 VS. 2024(USD MILLION)
  • 4.5. ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE, 2019 VS. 2024(USD MILLION)
  • 4.6. ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION

5. MARKET OVERVIEW

  • 5.1. MARKET DYNAMICS
    • 5.1.1. DRIVERS
      • 5.1.1.1. Rising prevalence of cancer
      • 5.1.1.2. Cancer awareness initiatives undertaken by governments and global health organizations
      • 5.1.1.3. Increasing preference for minimally invasive biopsies
    • 5.1.2. RESTRAINTS
      • 5.1.2.1. Risk of infections associated with the use of aspiration and biopsy needles
    • 5.1.3. OPPORTUNITIES
      • 5.1.3.1. Emerging economies
    • 5.1.4. CHALLENGES
      • 5.1.4.1. Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists
  • 5.2. INDUSTRY TRENDS
    • 5.2.1. EMERGENCE OF LIQUID BIOPSY

6. ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. BIOPSY NEEDLES
    • 6.2.1. BIOPSY NEEDLES MARKET SPLIT, BY SITE, 2017-2024(USD MILLION)
    • 6.2.2. BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2017-2024(USD MILLION)
    • 6.2.3. BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2017-2024(USD MILLION)
    • 6.2.4. CNB NEEDLES
      • 6.2.4.1. Low procedural costs, accuracy, and rapidity of core needle biopsy procedures will drive demand for associated needles
    • 6.2.5. CNB NEEDLES MARKET SPLIT, BY SITE, 2017-2024(USD MILLION)
    • 6.2.6. CNB NEEDLES MARKET SPLIT, BY PROCEDURE, 2017-2024(USD MILLION)
    • 6.2.7. CNB NEEDLES MARKET SPLIT, BY END USER, 2017-2024(USD MILLION)
    • 6.2.8. VAB NEEDLES
      • 6.2.8.1. High diagnostic specificity of vacuum-assisted biopsy is likely to drive market growth
    • 6.2.9. VAB NEEDLES MARKET SPLIT, BY SITE, 2017-2024(USD MILLION)
    • 6.2.10. VAB NEEDLES MARKET SPLIT, BY PROCEDURE, 2017-2024(USD MILLION)
    • 6.2.11. VAB NEEDLES MARKET SPLIT, BY END USER, 2017-2024(USD MILLION)
  • 6.3. ASPIRATION NEEDLES
    • 6.3.1. LOW ACCURACY AND THE POSSIBILITY OF FALSE-POSITIVE RESULTS HAVE HINDERED THE ADOPTION OF ASPIRATION NEEDLES
    • 6.3.2. ASPIRATION NEEDLES MARKET SPLIT, BY SITE, 2017-2024(USD MILLION)
    • 6.3.3. ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE, 2017-2024(USD MILLION)
    • 6.3.4. ASPIRATION NEEDLES MARKET SPLIT, BY END USER, 2017-2024(USD MILLION)

7. ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE

  • 7.1. INTRODUCTION
  • 7.2. IMAGE-GUIDED PROCEDURES
    • 7.2.1. ULTRASOUND
      • 7.2.1.1. Ultrasound is gradually becoming the most important adjunctive imaging modality for cancer diagnosis
    • 7.2.2. STEREOTACTIC
      • 7.2.2.1. Stereotactic-guided biopsy can evaluate tiny masses which are not visible through ultrasound
    • 7.2.3. MRI
      • 7.2.3.1. High cost, limited reimbursement, and lengthy procedure-

key factors restraining the market growth 56

    • 7.2.4. OTHER IMAGE-GUIDED PROCEDURES
  • 7.3. NONIMAGE-GUIDED PROCEDURES
    • 7.3.1. NONIMAGE-GUIDED PROCEDURES ARE MAJORLY PERFORMED IN SUPERFICIAL AREAS OF SUSPICIOUS ABNORMALITY

8. ASPIRATION AND BIOPSY NEEDLES MARKET, BY SITE

  • 8.1. INTRODUCTION
  • 8.2. BREAST
    • 8.2.1. INCREASING AWARENESS OF BREAST CANCER TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
  • 8.3. LUNG
    • 8.3.1. GROWING PREVALENCE OF LUNG CANCER TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
  • 8.4. COLORECTAL
    • 8.4.1. ADVANCEMENTS IN ALTERNATIVE DIAGNOSIS TECHNIQUES TO REDUCE THE ADOPTION OF COLORECTAL BIOPSY NEEDLES
  • 8.5. PROSTATE
    • 8.5.1. AVAILABILITY OF FUNDS FOR PROSTATE CANCER RESEARCH BY DIFFERENT GOVERNMENT AUTHORITIES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
  • 8.6. KIDNEY
    • 8.6.1. RISING PREVALENCE OF KIDNEY CANCER TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
  • 8.7. BONE AND BONE MARROW
    • 8.7.1. RISING INCIDENCE OF BONE CANCER ACROSS THE GLOBE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
  • 8.8. OTHER SITES

9. ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. The US dominates the North American aspiration and biopsy needles market primarily due to a large number of diagnostic imaging procedures performed in the country
    • 9.2.2. CANADA
      • 9.2.2.1. Rising prevalence of cancer is supporting the adoption of aspiration and biopsy needles in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. High healthcare spending and per capita healthcare spending in the country to support market growth
    • 9.3.2. UK
      • 9.3.2.1. Growing awareness and support for cancer-related activities are propelling the growth of the aspiration and biopsy needles market in the country
    • 9.3.3. FRANCE
      • 9.3.3.1. France to register the highest growth in the European aspiration and biopsy needles market
    • 9.3.4. REST OF EUROPE
  • 9.4. APAC
    • 9.4.1. JAPAN
      • 9.4.1.1. Presence of a well-developed healthcare system, coupled with the availability of a universal healthcare reimbursement policy, is aiding the growth of the aspiration and biopsy needles market in Japan
    • 9.4.2. CHINA
      • 9.4.2.1. Rising prevalence of cancer and the growing spending capacity of the middle-class population to drive the market for aspiration and biopsy needles in China
    • 9.4.3. INDIA
      • 9.4.3.1. Presence of a large patient population and growing access to healthcare facilities to support market growth
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. REST OF WORLD(ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET RANKING ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. ACQUISITIONS
  • 10.4. COMPETITIVE LEADERSHIP MAPPING
    • 10.4.1. COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS(2017)
      • 10.4.1.1. Visionary leaders
      • 10.4.1.2. Innovators
      • 10.4.1.3. Dynamic players
      • 10.4.1.4. Emerging companies

11. COMPANY PROFILES(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1. ARGON MEDICAL DEVICES, INC.
  • 11.2. BECTON, DICKINSON AND COMPANY(BD)
  • 11.3. BOSTON SCIENTIFIC CORPORATION
  • 11.4. CARDINAL HEALTH, INC.
  • 11.5. CONMED CORPORATION
  • 11.6. COOK GROUP INCORPORATED
  • 11.7. HAKKO CO.,LTD. MEDICAL DEVICE DIVISION
  • 11.8. INRAD INC.
  • 11.9. MEDTRONIC, PLC
  • 11.10. MERIT MEDICAL SYSTEMS
  • 11.11. OLYMPUS CORPORATION
  • 11.12. RANFAC CORPORATION
  • 11.13. REMINGTON MEDICAL INC.
  • 11.14. SOMATEX MEDICAL TECHNOLOGIES
  • 11.15. STRYKER CORPORATION

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS
Back to Top